US Patent Issued to GALAXY BIOTECH on July 14 for "Monoclonal antibodies to fibroblast growth factor receptor 2" (California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,897, issued on July 14, was assigned to GALAXY BIOTECH LLC (Cupertino, Calif.).

"Monoclonal antibodies to fibroblast growth factor receptor 2" was invented by Kyung Jin Kim (Cupertino, Calif.), Wei-Meng Zhao (Palo Alto, Calif.), Hangil Park (San Francisco) and Maximiliano Vasquez (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient."

The patent was filed on March 10, 2023, under Application No....